4-喹唑啉胺,6,7-二甲氧基-N-[4-(苯基甲氧基)苯基]- | 179248-61-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 中文名称: 4-喹唑啉胺,6,7-二甲氧基-N-[4-(苯基甲氧基)苯基]-
• 英文名称: N-(4-(benzyloxy)phenyl)-6,7-dimethoxyquinazolin-4-amine
• 英文别名: 4557W；4-(4'-benzyloxy-phenylamino)-6,7-dimethoxyquinazoline；EGFR/ErbB-2 Inhibitor；6,7-dimethoxy-N-(4-phenylmethoxyphenyl)quinazolin-4-amine
• CAS: 179248-61-4
• 化学式: C₂₃H₂₁N₃O₃
• 分子量: 387.438
• InChiKey: DNOKYISWMVFYFA-UHFFFAOYSA-N

物化性质

• 沸点：
  560.6±50.0 °C(Predicted)
• 密度：
  1.254±0.06 g/cm3(Predicted)
• 溶解度：
  DMSO 中≤1mg/ml；二甲基甲酰胺中10mg/ml

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  29
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  65.5
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  4-苄氧基苯胺 、 4-氯-6,7-二甲氧基喹唑啉 在 N,N-二异丙基乙胺 作用下， 以 乙醇 为溶剂， 反应 18.0h， 以84%的产率得到4-喹唑啉胺,6,7-二甲氧基-N-[4-(苯基甲氧基)苯基]-
  参考文献：
  名称：

  Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines

  摘要：

  We screened a series of 4-anilinoquinolines and 4-anilinoquinazolines and identified novel inhibitors of Mycobacterium tuberculosis (Mtb). The focused 4-anilinoquinoline/quinazoline scaffold arrays yielded compounds with high potency and the identification of 6,7-dimethoxy-N-(4-((4-methylbenzyl) oxy) phenyl) quinolin-4-amine (34) with an MIC90 value of 0.63-1.25 mu M. We also defined a series of key structural features, including the benzyloxy aniline and the 6,7-dimethoxy quinoline ring, that are important for Mtb inhibition. Importantly the compounds showed very limited toxicity and scope for further improvement by iterative medicinal chemistry.

  DOI：

  10.1016/j.bmcl.2019.07.012

文献信息

• COMPOSITION FOR PROMOTING CARDIAC DIFFERENTIATION OF PLURIPOTENT STEM CELL COMPRISING EGFR INHIBITOR
  申请人：KYOTO UNIVERSITY

  公开号：US20160002600A1

  公开（公告）日：2016-01-07

  The present invention provides a composition for promoting cardiac differentiation of a pluripotent stem cell containing an EGFR inhibitor. The present invention also provides a kit for promoting cardiac differentiation containing an EGFR inhibitor and a method for inducing cardiac differentiation of a pluripotent stem cell comprising culturing the pluripotent stem cell in a medium containing an EGFR inhibitor.

  本发明提供了一种含有EGFR抑制剂的促进多能干细胞心脏分化的组合物。本发明还提供了一种含有EGFR抑制剂的促进心脏分化的试剂盒，以及一种诱导多能干细胞心脏分化的方法，包括在含有EGFR抑制剂的培养基中培养多能干细胞。
• METHOD FOR DETERMINING SENSITIVITY OF TUMOR CELLS TO TYROSINE KINASE INHIBITOR AND COMPUTER PROGRAM PRODUCT
  申请人：KAWAI Masaaki

  公开号：US20110318768A1

  公开（公告）日：2011-12-29

  The present invention provides a method for determining sensitivity of the tumor cells to an EGFR and/or HER 2 inhibitor by evaluating inhibitory capacity of an Src inhibitor in a sample for measuring tyrosine kinase activity which is prepared from a biological sample containing tumor cells, a computer program and a method for determining effectiveness.

  本发明提供了一种方法，通过评估样本中Src抑制剂的抑制能力，测量来自含有肿瘤细胞的生物样本的酪氨酸激酶活性，以确定肿瘤细胞对EGFR和/或HER2抑制剂的敏感性，以及一种用于确定有效性的计算机程序和方法。
• PROMOTER OF DIFFERENTIATION OF PLURIPOTENT STEM CELL INTO MYOCARDIUM, WHICH COMPRISES EGF RECEPTOR INHIBITOR
  申请人：Kyoto University

  公开号：EP2966166A1

  公开（公告）日：2016-01-13

  The present invention provides a composition for promoting cardiac differentiation of a pluripotent stem cell containing an EGFR inhibitor. The present invention also provides a kit for promoting cardiac differentiation containing an EGFR inhibitor and a method for inducing cardiac differentiation of a pluripotent stem cell comprising culturing the pluripotent stem cell in a medium containing an EGFR inhibitor.

  本发明提供了一种含有表皮生长因子受体抑制剂的促进多能干细胞心脏分化的组合物。本发明还提供了一种含有表皮生长因子受体抑制剂的促进心脏分化的试剂盒，以及一种诱导多能干细胞心脏分化的方法，该方法包括在含有表皮生长因子受体抑制剂的培养基中培养多能干细胞。
• METHOD FOR INDUCING MYOCARDIAL DIFFERENTIATION OF PLURIPOTENT STEM CELLS USING LOW-MOLECULAR COMPOUND
  申请人：Kyoto University

  公开号：EP3150705A1

  公开（公告）日：2017-04-05

  The present invention provides a method for inducing cardiac differentiation of a pluripotent stem cell, which comprises the steps of (1) culturing a pluripotent stem cell in a medium containing a WNT signaling activator and a PCK activator and (2) culturing the cell after the step (1) in a medium containing a WNT signaling inhibitor, a Src inhibitor, and an EGFR inhibitor.

  本发明提供了一种诱导多能干细胞心脏分化的方法，该方法包括以下步骤：（1）在含有WNT信号激活剂和PCK激活剂的培养基中培养多能干细胞；（2）在步骤（1）之后，在含有WNT信号抑制剂、Src抑制剂和表皮生长因子受体抑制剂的培养基中培养细胞。
• FREEZING METHOD FOR AGGREGATES OF PLURIPOTENT STEM CELL-DERIVED MYOCARDIAL CELLS
  申请人：Kyoto University

  公开号：EP3431584A1

  公开（公告）日：2019-01-23

  The disclosure provides a method of freezing an aggregate of pluripotent stem cell-derived cardiomyocytes, comprising: (i) immersing an aggregate of pluripotent stem cell-derived cardiomyocytes in a cryoprotective solution; and (ii) freezing the aggregate immersed in the cryoprotective solution. The disclosure also provides a frozen aggregate of pluripotent stem cell-derived cardiomyocytes frozen by the method.

  本公开提供了一种冷冻多能干细胞衍生的心肌细胞集合体的方法，包括 (i) 将多能干细胞衍生的心肌细胞聚集体浸入低温保护溶液中；以及 (ii) 冻结浸泡在低温保护溶液中的聚集体。 本公开还提供了通过该方法冷冻的多能干细胞衍生的心肌细胞的冷冻集合体。